Literature DB >> 23348209

A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.

Brett Delahunt1, Jesse K McKenney, Christine M Lohse, Bradley C Leibovich, Robert Houston Thompson, Stephen A Boorjian, John C Cheville.   

Abstract

Grading of renal cell carcinoma (RCC) has prognostic significance, and there is recent consensus by the International Society of Urological Pathology (ISUP) that for clear cell and papillary RCC, grading should primarily be based on nucleolar prominence. Microscopic tumor necrosis also predicts outcome independent of tumor grading. This study was undertaken to assess whether the incorporation of microscopic tumor necrosis into the ISUP grading system provides survival information superior to ISUP grading alone. Data on 3017 patients treated surgically for clear cell RCC, 556 for papillary RCC, and 180 for chromophobe RCC were retrieved from the Mayo Clinic Registry. Median follow-up periods were 8.9, 9.7, and 8.5 years, respectively. Four proposed grades were defined: grade 1: ISUP grade 1+ISUP grade 2 without necrosis; grade 2: ISUP grade 2 with necrosis+ISUP grade 3 without necrosis; grade 3: ISUP grade 3 with necrosis+ISUP grade 4 without necrosis; grade 4: ISUP grade 4 with necrosis or sarcomatoid/rhabdoid tumors. There was a significant difference in survival between each of the grades for clear cell RCC, and the concordance index was superior to that of ISUP grading. The proposed grading system also outperformed the ISUP grading system when cases were stratified according to the TNM stage. Similar results were not obtained for papillary RCC or chromophobe RCC. We conclude that grading for clear cell RCC should be based on nucleolar prominence and necrosis, that ISUP grading should be used for papillary RCC, and that chromophobe RCC should not be graded.

Entities:  

Mesh:

Year:  2013        PMID: 23348209     DOI: 10.1097/PAS.0b013e318270f71c

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  31 in total

1.  Fuhrman grading is inappropriate for papillary renal cell carcinoma.

Authors:  Brett Delahunt; Lars Egevad; John R Srigley; Hemamali Samaratunga
Journal:  World J Urol       Date:  2017-12-18       Impact factor: 4.226

2.  Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma.

Authors:  F Cornelis; E Tricaud; A S Lasserre; F Petitpierre; J C Bernhard; Y Le Bras; M Yacoub; M Bouzgarrou; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2014-08-13       Impact factor: 5.315

3.  Renal Tumours in Adults with Correlation between Fuhrman Grading and Proliferative Marker.

Authors:  Sabuj Ghana Mukhopadhyay; Krishnendu Mukherjee; Asim Kr Manna
Journal:  Iran J Pathol       Date:  2015

4.  The accuracy of renal tumor biopsy: analysis from a national prospective study.

Authors:  J C Bernhard; P Bigot; G Pignot; H Baumert; L Zini; H Lang; M Crepel; P Monod; L Salomon; L Bellec; M Roupret; M Schneider; E Xylinas; P Paparel; F Bruyere; J Berger; J P Ansieau; P Gimel; F Salome; C Castagnola; C Pfister; J M Legraverend; M O Timsit; L Le Pellec; J L Auberget; E Rolland; R Mallet; A Mejean; J J Patard
Journal:  World J Urol       Date:  2014-11-06       Impact factor: 4.226

5.  Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.

Authors:  Levente Kuthi; Alex Jenei; Adrienn Hajdu; István Németh; Zoltán Varga; Zoltán Bajory; László Pajor; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2016-12-28       Impact factor: 3.201

6.  Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2.

Authors:  Sean F Altekruse; Lois Dickie; Xiao-Cheng Wu; Mei-Chin Hsieh; Manxia Wu; Richard Lee; Scott Delacroix
Journal:  Cancer       Date:  2014-12-01       Impact factor: 6.860

Review 7.  Omics Profiling in Precision Oncology.

Authors:  Kun-Hsing Yu; Michael Snyder
Journal:  Mol Cell Proteomics       Date:  2016-04-20       Impact factor: 5.911

8.  Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Kaitlin M Woo; Camelia S Sima; David J Finley; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2014-08       Impact factor: 15.609

9.  Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Authors:  Francisco Javier Queipo Gutiérrez; Ángel Panizo; Antonio Tienza; Irene Rodriguez; Jesús Javier Sola; Jordi Temprana-Salvador; Inés de Torres; Javier Pardo-Mindán
Journal:  Virchows Arch       Date:  2018-06-21       Impact factor: 4.064

10.  Comprehensive evaluation of 68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma.

Authors:  Jie Gao; Qinfeng Xu; Yao Fu; Kuiqiang He; Chengwei Zhang; Qing Zhang; Jiong Shi; Xiaozhi Zhao; Feng Wang; Hongqian Guo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.